| 2022 |
Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink
10.1371/journal.pmed.1003870
Authors: H. Strongman, H. Carreira, B. De Stavola, K. Bhaskaran, D. Leon |
| 2022 |
Surgical treatment, complications, reoperations, and healthcare costs among patients with clavicle fracture in England
10.1186/s12891-022-05075-5
Authors: S. Wolf, A. Chitnis, A. Manoranjith, M. Vanderkarr, J. Plaza, L. Gador, C. Holy, C. Sparks, S. Lambert |
| 2022 |
Clustering of comorbidities and associated outcomes in people with osteoarthritis - A UK Clinical Practice Research Datalink study
10.1016/j.joca.2021.12.013
Authors: S. Swain, C. Coupland, V. Strauss, C. Mallen, C. Kuo, A. Sarmanova, S. Bierma-Zeinstra, M. Englund, D. Prieto-Alhambra, M. Doherty, W. Zhang |
| 2022 |
First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases
10.1007/s41030-021-00179-0
Authors: C. Bloom, J. Montonen, O. Jöns, E. Garry, S. Bhatt |
| 2022 |
UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): what does analysis of linked, routinely collected national data sets tell us about mid-late term revision risk after hip replacement? Retrospective cohort study
10.1136/bmjopen-2021-050877
Authors: L. Smith, C. Garriga, S. Kingsbury, R. Pinedo-Villanueva, A. Delmestri, N. Arden, M. Stone, P. Conaghan, A. Judge |
| 2022 |
Primary care and cancer: an analysis of the impact and inequalities of the COVID-19 pandemic on patient pathways
10.1136/bmjopen-2021-059374
Authors: T. Watt, R. Sullivan, A. Aggarwal |
| 2022 |
Ethnic disparities in mortality among overweight or obese adults with newly diagnosed type 2 diabetes: a population-based cohort study
10.1007/s40618-021-01736-9
Authors: B. Iyen, Y. Vinogradova, R. Akyea, S. Weng, N. Qureshi, J. Kai |
| 2022 |
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study
10.1093/aje/kwac021
Authors: R. Pradhan, E. Patorno, H. Tesfaye, S. Schneeweiss, H. Yin, J. Franklin, A. Pawar, C. Santella, O. H. Y. Yu, C. Renoux, L. Azoulay |
| 2022 |
Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink
10.2217/cer-2021-0305
Authors: C. Foch, A. Allignol, T. Hohenberger, E. Boutmy, S. Schaefer, U. Hostalek |
| 2022 |
Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case-control study
10.1186/s12933-021-01432-1
Authors: Charlier SH, C. Meier, S. Jick, C. Meier, C. Becker |
| 2022 |
Opioid use prior to total knee replacement: comparative analysis of trends in England and Sweden
10.1016/j.joca.2022.02.621
Authors: D. Yu, C. Hellberg, T. Appleyard, A. Dell'Isola, G. Thomas, A. Turkiewicz, M. Englund, G. Peat |
| 2022 |
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany
10.1007/s40261-022-01120-2
Authors: E. Rivero-Ferrer, M. Olesen, E. Plana, J. Aguado, N. Saigi-Morgui, A. Rubino, S. Daoud, A. Lei, S. Perez-Gutthann, T. Schink, N. Kristiansen, J. Hallas, A. Pottegard, C. Rebordosa |
| 2022 |
UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): what does analysis of linked, routinely collected national datasets tell us about mid-late term revision risk after knee replacement?
10.1136/bmjopen-2020-046900
Authors: L. Smith, C. Garriga, S. Kingsbury, R. Pinedo-Villanueva, A. Delmestri, N. Arden, M. Stone, P. Conaghan, A. Judge |
| 2022 |
Trends in the Annual Consultation Incidence and Prevalence of Low Back Pain and Osteoarthritis in England from 2000 to 2019: Comparative Estimates from Two Clinical Practice Databases
10.2147/clep.s337323
Authors: D. Yu, M. Missen, K. Jordan, J. Edwards, J. Bailey, R. Wilkie, J. Fitzpatrick, N. Ali, P. Niblett, G. Peat |
| 2022 |
Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20-59 Years in the United Kingdom's CPRD 1995-2015
10.2147/clep.s341048
Authors: O. Ayodele, H. Cabral, D. McManus, S. Jick |
| 2022 |
Treatment Transitions in Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases
10.1007/s41030-021-00180-7
Authors: C. Bloom, J. Montonen, O. Jöns, E. Garry, S. Bhatt |
| 2022 |
Transparency of high-dimensional propensity score analyses: guidance for diagnostics and reporting
10.1002/pds.5412
Authors: J. Tazare, R. Wyss, J. Franklin, L. Smeeth, S. Evans, S. Wang, S. Schneeweiss, I. Douglas, J. Gagne, E. Williamson |
| 2022 |
Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
10.1007/s00198-021-06262-1
Authors: S. Khalid, S. Calderon-Larranaga, A. Sami, S. Hawley, A. Judge, N. Arden, T. van Staa, C. Cooper, B. Abrahamsen, M. Javaid, D. Prieto-Alhambra |
| 2022 |
Long-Term patterns of cancer incidence among patients with and without type 2 diabetes in the United Kingdom
10.1016/j.diabres.2022.109229
Authors: R. Pradhan, O. Yu, R. Platt, L. Azoulay |
| 2022 |
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes
10.2337/dc21-1953
Authors: R. Pradhan, H. Yin, O. Yu, L. Azoulay |
| 2022 |
Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
10.1183/23120541.00606-2021
Authors: H. Ashdown, M. Smith, E. McFadden, I. Pavord, C. Butler, M. Bafadhel |
| 2022 |
The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care
10.1016/s2666-7568(21)00281-6
Authors: E. Herrett, H. Strongman, S. Gadd, L. Tomlinson, D. Nitsch, K. Bhaskaran, E. Williamson, T. Van Staa, R. Sofat, A. Timmis, S. Wells, L. Smeeth, R. Jackson |
| 2022 |
Screening for type 2 diabetes after a diagnosis of gestational diabetes by ethnicity: A retrospective cohort study
10.1016/j.pcd.2022.03.008
Authors: E. Vounzoulaki, K. Khunti, J. Miksza, B. Tan, M. Davies, C. Gillies |
| 2022 |
Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
10.2147/copd.s346591
Authors: H. Whittaker, A. Rubino, H. Mullerova, T. Morris, P. Varghese, Y. Xu, E. de Nigris, J. Quint |
| 2022 |
The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records
10.1186/s12916-022-02247-x
Authors: R. Joseph, R. Jack, R. Morriss, R. Knaggs, D. Butler, C. Hollis, J. Hippisley-Cox, C. Coupland |
| 2022 |
Immortal time bias for life-long conditions in retrospective observational studies using electronic health records
10.1186/s12874-022-01581-1
Authors: F. Tyrer, K. Bhaskaran, M. Rutherford |
| 2022 |
Significant reduction in chronic kidney disease progression with sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes in a UK clinical setting
10.1111/dom.14799
Authors: I. Idris, R. Zhang, J. Mamza, M. Ford, T. Morris, A. Banerjee, K. Khunti |
| 2022 |
Effectiveness and safety of apixaban vs. rivaroxaban in patients with atrial fibrillation and type 2 diabetes mellitus
10.1055/a-1798-2116
Authors: Roy Chowdhury, J. Michaud, O. H. Y. Yu, H. Yin, L. Azoulay, C. Renoux |
| 2022 |
Comparing antibiotic prescribing between clinicians in UK primary care: an analysis in a cohort study of eight different measures of antibiotic prescribing
10.1136/bmjqs-2020-012108
Authors: T. Van Staa, Y. Li, N. Gold, T. Chadborn, W. Welfare, V. Palin, D. Ashcroft, J. Bircher |
| 2022 |
Statin use is associated with lower risk of dementia in stroke patients: a community-based cohort study with inverse probability weighted marginal structural model analysis
10.1007/s10654-022-00856-7
Authors: Z. Yang, S. Toh, X. Li, D. Edwards, C. Brayne, J. Mant |
| 2022 |
Epidemiology of prurigo nodularis in England: a retrospective database analysis
10.1111/bjd.21032
Authors: C. Morgan, M. Thomas, S. Ständer, Z. Jabbar-Lopez, C. Piketty, S. Gabriel, C. Currie, J. Puelles |
| 2022 |
Antipsychotic treatment patterns in Alzheimer's disease patients with agitation: a cohort study using the UK clinical practice research datalink
10.1080/03007995.2022.2029381
Authors: C. Tran, M. Bøg, S. Collings, M. Johnson, N. Qizilbash, S. Lind, R. Baker, K. Jørgensen |
| 2022 |
β-Blockers and the Risk of Depression: A Matched Case-Control Study
10.1007/s40264-021-01140-5
Authors: D. Bornand, D. Reinau, S. Jick, C. Meier |
| 2022 |
Alcohol use recording in adults with depression in English primary care: a cross-sectional study
10.1136/bmjopen-2021-055975
Authors: E. Adesanya, S. Cook, E. Crellin, S. Langan, K. Mansfield, L. Smeeth, E. Herrett |
| 2022 |
Burden of Pertussis in Individuals with a Diagnosis of Asthma: A Retrospective Database Study in England
10.2147/jaa.s335960
Authors: A. Bhavsar, E. Aris, L. Harrington, J. Simeone, A. Ramond, D. Lambrelli, A. Papi, L. Boulet, K. Meszaros, N. Jamet, Y. Sergerie, P. Mukherjee |
| 2022 |
Respiratory-related death in individuals with incident asthma and COPD: a competing risk analysis
10.1186/s12890-022-01823-4
Authors: A. Gayle, C. Minelli, J. Quint |
| 2022 |
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
10.1136/bmjdrc-2021-002517
Authors: T. Weiss, L. Yang, R. Carr, S. Pal, B. Sawhney, R. Boggs, S. Rajpathak, K. Iglay |
| 2022 |
Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study
10.1186/s12884-022-04442-3
Authors: S. Lee, A. Azcoaga-Lorenzo, U. Agrawal, J. Kennedy, A. Fagbamigbe, H. Hope, A. Subramanian, A. Anand, B. Taylor, C. Nelson-Piercy, C. Damase-Michel, C. Yau, F. Crowe, G. Santorelli, K. Eastwood, Z. Vowles, M. Loane, N. Moss, P. Brocklehurst, R. Plachcinski, S. Thangaratinam, M. Black, D. O'Reilly, K. Abel, S. Brophy, K. Nirantharakumar, C. McCowan |
| 2022 |
Continuity of GP care for patients with dementia: impact on prescribing and the health of patients
10.3399/bjgp.2021.0413
Authors: J. Delgado, P. Evans, D. Gray, K. Sidaway-Lee, L. Allan, L. Clare, C. Ballard, J. Masoli, J. Valderas, D. Melzer |
| 2022 |
Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from 1997 to across the COVID-19 pandemic in 2021
10.1136/annrheumdis-2021-221989
Authors: A. Abhishek, L. Tata, M. Mamas, A. Avery |
| 2022 |
The feasibility of pragmatic influenza vaccine randomized controlled real-world trials in Denmark and England
10.1038/s41541-022-00444-6
Authors: J. Nealon, D. Modin, R. Ghosh, D. Rudin, G. Gislason, H. Booth, J. Jensen, R. Williams, H. Shepherd, E. Yelland, H. Bricout, S. Chaves, T. Biering-Sørensen |
| 2022 |
No evidence that herpes zoster is associated with increased risk of dementia diagnosis
10.1002/acn3.51525
Authors: C. Warren-Gash, E. Williamson, S. Shiekh, J. Borjas-Howard, N. Pearce, J. Breuer, L. Smeeth |
| 2022 |
Investigating the optimal handling of uncertain pregnancy episodes in the CPRD GOLD Pregnancy Register: a methodological study using UK primary care data
10.1136/bmjopen-2021-055773
Authors: J. Campbell, K. Bhaskaran, S. Thomas, R. Williams, H. McDonald, C. Minassian |
| 2022 |
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
10.1093/eurheartj/ehac056
Authors: S. Hageman, A. McKay, P. Ueda, L. Gunn, T. Jernberg, E. Hagström, D. Bhatt, P. Steg, K. Läll, R. Mägi, Nordbø Gynnild, H. Ellekjær, I. Saltvedt, J. Tuñón, I. Mahíllo, Á Aceña, K. Kaminski, M. Chlabicz, E. Sawicka, T. Tillman, J. McEvoy, E. Di Angelantonio, I. Graham, D. De Bacquer, K. Ray, J. Dorresteijn, F. Visseren |
| 2022 |
Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England
10.1186/s12933-021-01435-y
Authors: S. Abner, C. Gillies, S. Shabnam, F. Zaccardi, S. Seidu, M. Davies, T. Adeyemi, K. Khunti, D. Webb |
| 2022 |
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
10.2337/dc21-1113
Authors: A. Wright, M. Carr, E. Kontopantelis, L. Leelarathna, H. Thabit, R. Emsley, I. Buchan, M. Mamas, T. van Staa, N. Sattar, D. Ashcroft, M. Rutter |
| 2022 |
Use of lifestyle interventions in primary care for individuals with newly diagnosed hypertension, hyperlipidaemia or obesity: a retrospective cohort study
10.1177/01410768221077381
Authors: J. Lemp, M. Nuthanapati, T. Bärnighausen, S. Vollmer, P. Geldsetzer, A. Jani |
| 2022 |
Reduction of Cardiovascular Disease and Mortality versus Risk of New Onset Diabetes with Statin Use in Patients with Rheumatoid Arthritis
10.1002/acr.24866
Authors: G. Ozen, S. Dell'Aniello, S. Pedro, K. Michaud, S. Suissa |
| 2022 |
Primary care clinical management following self-harm during the first wave of COVID-19 in the UK: population-based cohort study
10.1136/bmjopen-2021-052613
Authors: S. Steeg, M. Carr, L. Trefan, D. Ashcroft, N. Kapur, E. Nielsen, B. McMillan, R. Webb |
| 2022 |
Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
10.1136/bmjopen-2021-055603
Authors: C. Clarke, E. Williamson, S. Denaxas, J. Carpenter, M. Thomas, H. Blackshaw, A. Schilder, C. Philpott, C. Hopkins, S. Morris |
